Report

Conducting Indirect Treatment Comparison and Network Meta-Analysis Studies Report 2
Conjoint Analysis Applications in Health - A Checklist
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations - ISPOR drug cost task force report - Part I
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective - ISPOR drug cost task force report - Part II
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective - ISPOR drug cost task force report - Part III
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and US Government Payers Perspectives ISPOR drug cost task force report - Part IV
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective - ISPOR drug cost task force report - Part V
Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective - ISPOR drug cost task force report - Part VI
Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification
The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report
Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources - Task Force Report Part III
Good research practices for comparative effectiveness research - bias & confounding in the design - Task Force Report Part II
Good research practices for comparative effectiveness research – defining, reporting & interpreting - Task Force Report Part I
Multinational Trials – Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data
Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures
Transferability of Economic Evaluations Across Jurisdictions - Good research practices task force report
Principles of Good Practice for Budget Impact Analysis I
Using Real-World Data for Coverage and Payment Decisions
Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials
Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures

Questions?

For any questions about this report please contact us.

Report

Conducting Indirect Treatment Comparison and Network Meta-Analysis Studies Report 2

Conjoint Analysis Applications in Health - A Checklist

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations - ISPOR drug cost task force report - Part I

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Societal Perspective - ISPOR drug cost task force report - Part II

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: A Managed Care Perspective - ISPOR drug cost task force report - Part III

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: Medicare, Medicaid and US Government Payers Perspectives ISPOR drug cost task force report - Part IV

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective - ISPOR drug cost task force report - Part V

Good Research Practices for Measuring Drug Costs in Cost-Effectiveness Analyses: An International Perspective - ISPOR drug cost task force report - Part VI

Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report

Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources - Task Force Report Part III

Good research practices for comparative effectiveness research - bias & confounding in the design - Task Force Report Part II

Good research practices for comparative effectiveness research – defining, reporting & interpreting - Task Force Report Part I

Multinational Trials – Recommendations on the Translations Required, Approaches to Using the Same Language in Different Countries, and the Approaches to Support Pooling the Data

Recommendations on Evidence Needed to Support Measurement Equivalence between Electronic and Paper-Based Patient-Reported Outcome (PRO) Measures

Transferability of Economic Evaluations Across Jurisdictions - Good research practices task force report

Principles of Good Practice for Budget Impact Analysis I

Using Real-World Data for Coverage and Payment Decisions

Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials

Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures

Questions?

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Your browser is out-of-date